Owner Janssen Pharmaceutica N.V.

Inventors Motte, Magali Madeleine Simone; Lancois, David Francis Alain; Dorange, Ismet; Villalgordo-Soto, Jose Manuel; Guillemont, Jerome Emile Georges; Simonnet, Yvan Rene Ferdinand; Koul, Anil; Andries, Koenraad Jozef Lodewijk Marcel

Agent Shelston IP

Pub. Number AU-A-2007328892

PCT Pub. Number WO2008/068272

Priority 06125545.1 06.12.06 EP

Filing date 4 December 2007

Wipo publication date 12 June 2008

A61K 31/47 (2006.01) - Quinolines

A61K 31/4995 (2006.01) - Pyrazines or piperazines forming part of bridged ring systems

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 215/22 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/227 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 487/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups